Security key
74168J101
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 181,672,212
- Total 13F shares
- 64,302,617
- Share change
- -4,507,355
- Total reported value
- $187,767,212
- Put/Call ratio
- 406%
- Price per share
- $2.92
- Number of holders
- 128
- Value change
- -$16,411,951
- Number of buys
- 63
- Number of sells
- 50
Report period
Q4 2024
Institutions
128
Top holders
10
PRME full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Prime Medicine, Inc. SEC filings
Prime Medicine, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74168J101
Recent filing periods:
Top shareholders of PRME - Prime Medicine, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Newpath Partners, L.P. |
13D/G
|
— |
4.7%
|
6,105,679
|
$9,769,086 | $0 | 31 Dec 2024 | |
| Alphabet Inc. |
13F
|
Company |
8.3%
|
15,062,498
|
$58,291,867 | — | 30 Sep 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
3.1%
|
5,660,719
|
$21,906,982 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.9%
|
5,266,775
|
$20,382,420 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
4,890,313
|
$18,925,511 | — | 30 Sep 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.1%
|
3,807,287
|
$14,735,000 | — | 30 Sep 2024 | |
| FMR LLC |
3/4/5
13F
|
Other* · Company |
2.1%
from 13F
|
8,462,946
|
$126,699,612 | — | 24 Oct 2022 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.8%
|
3,190,455
|
$12,347,061 | — | 30 Sep 2024 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.8%
|
3,182,455
|
$12,284,276 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,198,240
|
$8,507,189 | — | 30 Sep 2024 | |
| Redmile Group, LLC |
13F
|
Company |
1.1%
|
2,074,350
|
$8,027,735 | — | 30 Sep 2024 | |
| MWG Management Ltd. |
13F
|
Company |
0.99%
|
1,792,210
|
$6,935,853 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.85%
|
1,545,961
|
$5,984,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
1,359,979
|
$5,264,487 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.63%
|
1,146,949
|
$4,438,693 | — | 30 Sep 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.59%
|
1,070,000
|
$4,140,900 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.57%
|
1,028,466
|
$3,980,163 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.49%
|
896,960
|
$3,471,235 | — | 30 Sep 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.41%
|
750,000
|
$2,902,500 | — | 30 Sep 2024 | |
| Greenwich Wealth Management LLC |
13F
|
Company |
0.4%
|
733,001
|
$2,837,000 | — | 30 Sep 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.39%
|
700,000
|
$2,709,000 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.38%
|
694,000
|
$2,685,780 | — | 30 Sep 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.3%
|
540,304
|
$2,090,976 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
524,548
|
$2,030,001 | — | 30 Sep 2024 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.28%
|
500,000
|
$1,935,000 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.27%
|
485,125
|
$1,877,434 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.26%
|
463,977
|
$1,795,591 | — | 30 Sep 2024 | |
| WESTWOOD HOLDINGS GROUP INC |
13F
|
Company |
0.25%
|
449,476
|
$1,739,472 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
392,443
|
$1,518,755 | — | 30 Sep 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.2%
|
367,175
|
$1,420,967 | — | 30 Sep 2024 | |
| Bollard Group LLC |
13F
|
Company |
0.2%
|
361,136
|
$1,398,000 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.18%
|
318,573
|
$1,232,878 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
300,391
|
$1,162,515 | — | 30 Sep 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.13%
|
242,160
|
$937,159 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
220,144
|
$851,957 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.09%
|
171,468
|
$663,581 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
139,451
|
$539,675 | — | 30 Sep 2024 | |
| FIL Ltd |
13F
|
Company |
0.07%
|
129,861
|
$502,562 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
129,714
|
$501,994 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.07%
|
124,369
|
$481,308 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.07%
|
119,900
|
$464,013 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
115,054
|
$445,259 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
114,907
|
$444,690 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.06%
|
108,374
|
$419,407 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.05%
|
99,060
|
$383,000 | — | 30 Sep 2024 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
0.05%
|
90,036
|
$348,439 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
84,697
|
$327,777 | — | 30 Sep 2024 | |
| CHELSEA COUNSEL CO |
13F
|
Company |
0.04%
|
78,690
|
$304,531 | — | 30 Sep 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.04%
|
76,456
|
$295,885 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
76,000
|
$294,120 | — | 30 Sep 2024 |
Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q4 2024
As of 31 Dec 2024,
Prime Medicine, Inc. - COMMON STOCK (PRME) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,302,617 shares.
The largest 10 holders included
Alphabet Inc., ARK Investment Management LLC, BlackRock, Inc., T. Rowe Price Investment Management, Inc., FMR LLC, VANGUARD GROUP INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., Redmile Group, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
129
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
113
Q4 2024 holders
128
Holder diff
15
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.